Common: Nervous system disorders: Headache.
Gastrointestinal disorders: Constipation, nausea, flatulence.
Uncommon: Nervous system disorders: Dizziness, somnolence.
Gastrointestinal disorders: Abdominal pain, abdominal discomfort, dry mouth, abdominal pain upper, vomiting, dyspepsia.
Skin and subcutaneous tissue disorders: Rash.
Rare: Immune system disorders: Hypersensitivity reaction, anaphylactic reaction (including anaphylactic shock), anaphylactoid reaction.
Nervous system disorders: Loss of consciousness, stupor, depressed level of consciousness, hypertonia, coordination abnormality.
Eye disorders: Miosis.
Gastrointestinal disorders: Ileus (including paralytic ileus), megacolon (including toxic megacolon), abdominal distension.
Skin and subcutaneous tissue disorders: Bullous eruption (including Stevens-Johnson syndrome, toxic epidermal necrolysis and erythema multiforme), angioedema, urticaria, pruritus.
Renal and urinary disorders: Urinary retention.
General disorders and administration site conditions: Fatigue.
View ADR Monitoring Form